Foresee Pharmaceuticals Data Breach

Alleged

Ransomware claim involving Foresee Pharmaceuticals

Published: Aug 18, 2026 INC Ransom
Threat Level
High
Confidence: High

Quick Summary

Alleged
Company
Foresee Pharmaceuticals
Industry
Biotechnology
Threat Actor
INC Ransom
Date of Incident
Aug 18, 2026

Executive Summary

Foresee Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in orphan diseases, was targeted by the INC Ransom ransomware group. The group added foreseepharma[.]com to its leak portal on August 18, 2026. This incident marks one of INC Ransom’s few recorded attacks against a healthcare target in the Asia-Pacific region, specifically Taiwan. Given the company’s focus on rare diseases, disruptions to research and proprietary data integrity are particularly critical, impacting the very core of its product development and operations. INC Ransom has claimed 42 other victims in the 60 days preceding this listing, with a significant concentration in Professional Services, Healthcare, and Business Services. The group primarily targets organizations in the United States, UAE, and Canada, making Taiwan-based targets less common for them. Notable recent healthcare-related victims include Lansing Urgent Care and Diabetes and Metabolism Specialists. The inclusion of Foresee Pharmaceuticals represents a deviation from INC Ransom’s typical targeting pattern, which predominantly focuses on North American and Middle Eastern entities.

Technical Analysis

SOCRadar’s analysis of stealer-log data for foreseepharma[.]com yielded no records. It is crucial to note that this absence of direct correlation does not confirm that the organization is unaffected. The stealer-log query was bounded and paginated, meaning that credentials could still exist under alternate or sibling corporate domains, or through employee personal email aliases that were not captured in the queried dataset. Furthermore, credentials may have been used and subsequently rotated before they were indexed in the feeds monitored. Given INC Ransom’s known operational pattern of leveraging infostealer-harvested credentials as an initial access vector, the lack of direct telemetry warrants continued vigilance. The null result from the stealer-log query does not rule out a potential compromise. Therefore, it is advisable for Foresee Pharmaceuticals to maintain continuous monitoring across related domains and employee accounts to detect any potential ongoing or future malicious activity. This posture is consistent with the threat actor’s reliance on compromised credentials for network intrusion.

Disclaimer

This report is intended for threat intelligence and security awareness purposes. SOCRadar does not host, redistribute or buy stolen data. All breach information reported here is collected from publicly accessible threat actor and ransomware portals. This content is intended to equip CTI teams with context around recent attacks. While we strive for accuracy, listings on ransomware leak and extortion sites cannot always be independently verified and may not reflect confirmed breaches. If you believe any data in this report is incorrect, please contact us.

Is your data on the Dark Web?
Check dark web exposure for free.